Skip to main content

All Clinical Trials are full and no longer enrolling new patients

Past clinical trials are listed below:

Ultraclear CLINICAL TRIAL

CLOSED

Women and men 60+ years old with skin types 1-4 and perioral and cheek wrinkles.

Patients will be treated with Ultraclear, an FDA cleared laser using fractionated technology to help reverse signs of aging, including wrinkles, sun spots, scars and pigmentation.

Patients will be treated by a board certified dermatologist and will receive 3 Ultraclear treatments 6-8 weeks apart. Follow up visits will take place 1 and 3 months after the third treatment.

Call our office 713-900-3900 or email us: info@dermlasersurgery.com to see if you are a candidate!

Sofwave Clinical Trial

CLOSED

Clinical trial of a newly FDA cleared device using ultrasound technology. This device treats facial lines & wrinkles and lifts the brow and skin on the neck & submental region.

Participants Must:

Please e-mail: info@dermlasersurgery.com or call 713-900-3900 and ask for Arely

Rosacea Study

CLOSED

Dr. Paul Friedman of Dermatology & Laser Surgery Center in Houston, TX is conducting a clinical trial, using the Vbeam Prima laser, to improve facial flushing, redness, and the appearance of visible blood vessels, when used in combination with a topical prescription cream (RHOFADE (oxymetazoline HCl) Cream, 1%) for erythematotelangiectatic rosacea.

The study treatment by the laser device heats the tiny, broken blood vessels on the face and should improve flushing and redness. The study will try to determine if the areas treated with the laser and the topical prescription cream will have improved outcomes, compared to what would have been obtained with the topical prescription cream alone. The VBEAM PRIMA device used in this study was recently cleared by the Food and Drug Administration (FDA). The topical prescription cream used in the study, Allergen’s RHOFADE (Oxymetazoline Hydrochloride) 1% Cream is FDA-cleared for the topical treatment of persistent facial erythema associated with rosacea in adults.

The treatment is a series of three treatments, each of which take about 15 minutes. Treatments are performed in the office. The trial is free and includes reimbursement of $75 for each tube of RHOFADE not covered by insurance.

Study candidates must meet the following criteria:

For more information about trial participation, please contact us: 713-900-3900

Melasma Study: laser combined with the tranexamic acid pill

CLOSED

Seeking healthy non-smoking male and female volunteers of all skin types of age 18 to 50 with moderate melasma or severe melasma. Participants will receive up to 5 monthly laser treatments to half the face and need to take a pill twice a day for 4 months. Follow up visits are required 1 month, 3 months and 6 months after the final treatment.  Compensation of up to $150 will be provided based on completed visits.

Inclusion Criteria:

Exclusion Criteria:

For More Information Contact The Research Department At
713-900-3900 or info@dermlasersugery.com